These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 9047952)

  • 1. [Disorders of organic acid metabolism].
    Tsuda M
    Ryoikibetsu Shokogun Shirizu; 1996; (15):81-4. PubMed ID: 9047952
    [No Abstract]   [Full Text] [Related]  

  • 2. [Myopathies with miscellaneous disorders related to mitochondrial fatty acid oxidation: defective synthesis of ketone body, long-chain fatty acid transport defect, and muscular coenzyme Q10 deficiency].
    Takusa Y; Yamaguchi S
    Ryoikibetsu Shokogun Shirizu; 2001; (36):90-4. PubMed ID: 11596461
    [No Abstract]   [Full Text] [Related]  

  • 3. Assays of fatty acid beta-oxidation activity.
    Bennett MJ
    Methods Cell Biol; 2007; 80():179-97. PubMed ID: 17445695
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluxing the mitochondria to insulin resistance.
    Watt MJ; Hevener AL
    Cell Metab; 2008 Jan; 7(1):5-6. PubMed ID: 18177719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fatty acid oxidation by intact cells and mitochondria of Torulopsis candida yeast].
    Il'chenko AP; Sapozhnikova GP; Lozinov AB
    Izv Akad Nauk SSSR Biol; 1977; (6):886-94. PubMed ID: 564361
    [No Abstract]   [Full Text] [Related]  

  • 6. Peroxisomes, lipid metabolism, and peroxisomal disorders.
    Wanders RJ
    Mol Genet Metab; 2004; 83(1-2):16-27. PubMed ID: 15464416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial fatty-acid oxidation disorders.
    Kompare M; Rizzo WB
    Semin Pediatr Neurol; 2008 Sep; 15(3):140-9. PubMed ID: 18708005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited disorders of mitochondrial fatty acid oxidation: a new responsibility for the neonatologist.
    Roe CR
    Semin Neonatol; 2002 Feb; 7(1):37-47. PubMed ID: 12069537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases.
    Shekhawat P; Bennett MJ; Sadovsky Y; Nelson DM; Rakheja D; Strauss AW
    Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1098-105. PubMed ID: 12582009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
    Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
    Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mitochondrial beta-oxidation defects: overview].
    Yamaguchi S
    Ryoikibetsu Shokogun Shirizu; 2001; (36):60-4. PubMed ID: 11596451
    [No Abstract]   [Full Text] [Related]  

  • 12. Fatty acid oxidation in malignant and normal livers. IV. The mechanism of the stimulatory effect of some alpha-oxy-acids on fatty acid oxidation in cellfree tissue preparations of normal livers.
    EMMELOT P; BOS CJ
    Enzymologia; 1954 Jul; 17(1):13-22. PubMed ID: 14353050
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
    Nakamuta M; Kohjima M; Morizono S; Kotoh K; Yoshimoto T; Miyagi I; Enjoji M
    Int J Mol Med; 2005 Oct; 16(4):631-5. PubMed ID: 16142397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid oxidation in malignant and normal livers. III. The stimulatory effect of alpha-oxycaproate on fatty acid oxidation of normal livers studied with C14.
    BARENDREGT TJ; EMMELOT P; BOS CJ
    Enzymologia; 1954 Jul; 17(1):9-12. PubMed ID: 14353049
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition and stimulation of long-chain fatty acid oxidation by chloroacetaldehyde and methylene blue in rats.
    Visarius TM; Stucki JW; Lauterburg BH
    J Pharmacol Exp Ther; 1999 May; 289(2):820-4. PubMed ID: 10215658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship.
    Gregersen N; Andresen BS; Corydon MJ; Corydon TJ; Olsen RK; Bolund L; Bross P
    Hum Mutat; 2001 Sep; 18(3):169-89. PubMed ID: 11524729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of silymarin and its combination with succinic acid on brain bioenergetics in rats with experimental inhibition of beta-oxidation of fatty acids].
    Vengerovskiĭ AI; Khazanov VA
    Eksp Klin Farmakol; 2007; 70(2):51-5. PubMed ID: 17523453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance.
    Koves TR; Ussher JR; Noland RC; Slentz D; Mosedale M; Ilkayeva O; Bain J; Stevens R; Dyck JR; Newgard CB; Lopaschuk GD; Muoio DM
    Cell Metab; 2008 Jan; 7(1):45-56. PubMed ID: 18177724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal pseudo-obstruction as a manifestation of impaired mitochondrial fatty acid oxidation.
    Gilbert J; Ibdah JA
    Med Hypotheses; 2005; 64(3):586-9. PubMed ID: 15617873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mitochondrial beta-oxidation defects].
    Woldseth B; Rootwelt T
    Tidsskr Nor Laegeforen; 2006 Mar; 126(6):756-9. PubMed ID: 16541168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.